MS4A1 (CD20, tumor infiltrating B-cell marker), and BACH2 (a well-known transcriptional regulator of B and TFH cells), two genes previously implicated in contributing to immune landscape differences between RSCC and LSCC [39], are more predominantly suppressed within distal tumors. Here, KRT20 is linked to neoplasm.